HEADER TRANSCRIPTION 14-NOV-19 6TFI TITLE PXR IN COMPLEX WITH THROMBIN INHIBITOR COMPOUND 17 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR SUBFAMILY 1 GROUP I MEMBER 2,NUCLEAR COMPND 3 RECEPTOR COACTIVATOR 1; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: ORPHAN NUCLEAR RECEPTOR PAR1,ORPHAN NUCLEAR RECEPTOR PXR, COMPND 6 PREGNANE X RECEPTOR,STEROID AND XENOBIOTIC RECEPTOR,SXR,NCOA-1,CLASS COMPND 7 E BASIC HELIX-LOOP-HELIX PROTEIN 74,BHLHE74,PROTEIN HIN-2,RIP160, COMPND 8 RENAL CARCINOMA ANTIGEN NY-REN-52,STEROID RECEPTOR COACTIVATOR 1,SRC- COMPND 9 1; COMPND 10 EC: 2.3.1.48; COMPND 11 ENGINEERED: YES; COMPND 12 MUTATION: YES; COMPND 13 OTHER_DETAILS: PXR, RESIDUES 129-434, K129G IS A CLONING ARTIFACT; COMPND 14 LINKER; SRC-1, RESIDUES 678-700,PXR, RESIDUES 129-434, K129G IS A COMPND 15 CLONING ARTIFACT; LINKER; SRC-1, RESIDUES 678-700 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1I2, PXR, NCOA1, BHLHE74, SRC1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PXR, SRC-1, CYP3A4 INDUCTION, PK OPTIMIZATION, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR R.C.HILLIG,V.PUETTER REVDAT 3 24-JAN-24 6TFI 1 REMARK REVDAT 2 25-NOV-20 6TFI 1 JRNL REVDAT 1 11-NOV-20 6TFI 0 JRNL AUTH A.HILLISCH,K.M.GERICKE,S.ALLERHEILIGEN,S.ROEHRIG,M.SCHAEFER, JRNL AUTH 2 A.TERSTEEGEN,S.SCHULZ,P.LIENAU,M.GNOTH,V.PUETTER,R.C.HILLIG, JRNL AUTH 3 S.HEITMEIER JRNL TITL DESIGN, SYNTHESIS, AND PHARMACOLOGICAL CHARACTERIZATION OF A JRNL TITL 2 NEUTRAL, NON-PRODRUG THROMBIN INHIBITOR WITH GOOD ORAL JRNL TITL 3 PHARMACOKINETICS. JRNL REF J.MED.CHEM. V. 63 12574 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 33108181 JRNL DOI 10.1021/ACS.JMEDCHEM.0C01035 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0238 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.48 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 65823 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.173 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.199 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2101 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.90 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4821 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.80 REMARK 3 BIN R VALUE (WORKING SET) : 0.3010 REMARK 3 BIN FREE R VALUE SET COUNT : 154 REMARK 3 BIN FREE R VALUE : 0.3240 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4847 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 89 REMARK 3 SOLVENT ATOMS : 360 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.61 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.92 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.60000 REMARK 3 B22 (A**2) : 0.25000 REMARK 3 B33 (A**2) : 0.35000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.113 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.108 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.080 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.569 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.968 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.956 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5185 ; 0.005 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 4914 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7002 ; 1.308 ; 1.651 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11398 ; 1.265 ; 1.574 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 635 ; 5.192 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 280 ;31.873 ;21.750 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 969 ;14.978 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 38 ;14.137 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 652 ; 0.074 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5686 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1110 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2447 ; 3.081 ; 3.055 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2446 ; 3.081 ; 3.054 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3068 ; 4.670 ; 6.827 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 3069 ; 4.669 ; 6.829 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2738 ; 4.209 ; 3.588 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2739 ; 4.208 ; 3.590 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3920 ; 6.625 ; 7.749 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 5987 ; 9.443 ;38.346 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 5911 ; 9.404 ;37.944 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 1 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 142 459 B 142 459 9742 0.10 0.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 142 A 434 REMARK 3 ORIGIN FOR THE GROUP (A): 9.1570 28.5080 30.2750 REMARK 3 T TENSOR REMARK 3 T11: 0.0633 T22: 0.0446 REMARK 3 T33: 0.0716 T12: 0.0141 REMARK 3 T13: -0.0002 T23: -0.0150 REMARK 3 L TENSOR REMARK 3 L11: 0.7286 L22: 0.4651 REMARK 3 L33: 1.3510 L12: -0.2822 REMARK 3 L13: -0.5148 L23: 0.1199 REMARK 3 S TENSOR REMARK 3 S11: -0.0108 S12: 0.0765 S13: -0.0316 REMARK 3 S21: -0.0259 S22: -0.1391 S23: 0.0309 REMARK 3 S31: -0.1509 S32: -0.0797 S33: 0.1499 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 443 A 460 REMARK 3 ORIGIN FOR THE GROUP (A): 1.6160 12.0150 18.3630 REMARK 3 T TENSOR REMARK 3 T11: 0.0913 T22: 0.2261 REMARK 3 T33: 0.1431 T12: -0.0430 REMARK 3 T13: 0.0148 T23: -0.1546 REMARK 3 L TENSOR REMARK 3 L11: 15.8410 L22: 7.1600 REMARK 3 L33: 7.1271 L12: -4.9965 REMARK 3 L13: -1.4977 L23: -1.0108 REMARK 3 S TENSOR REMARK 3 S11: -0.2812 S12: 0.9102 S13: -0.2728 REMARK 3 S21: -0.0650 S22: -0.0786 S23: 0.3005 REMARK 3 S31: 0.7670 S32: -0.6110 S33: 0.3598 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 138 B 431 REMARK 3 ORIGIN FOR THE GROUP (A): 54.1490 42.1140 7.7730 REMARK 3 T TENSOR REMARK 3 T11: 0.0586 T22: 0.0597 REMARK 3 T33: 0.0549 T12: -0.0114 REMARK 3 T13: -0.0183 T23: -0.0078 REMARK 3 L TENSOR REMARK 3 L11: 1.5920 L22: 0.6578 REMARK 3 L33: 0.6637 L12: 0.3640 REMARK 3 L13: 0.1502 L23: -0.5334 REMARK 3 S TENSOR REMARK 3 S11: 0.0795 S12: -0.0854 S13: -0.0963 REMARK 3 S21: 0.0118 S22: -0.0214 S23: -0.0356 REMARK 3 S31: 0.0457 S32: 0.0250 S33: -0.0581 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 444 B 461 REMARK 3 ORIGIN FOR THE GROUP (A): 55.7740 27.8840 -8.2460 REMARK 3 T TENSOR REMARK 3 T11: 0.3549 T22: 0.1270 REMARK 3 T33: 0.2725 T12: -0.0528 REMARK 3 T13: 0.1313 T23: -0.1507 REMARK 3 L TENSOR REMARK 3 L11: 1.6784 L22: 3.5942 REMARK 3 L33: 17.1256 L12: -1.5905 REMARK 3 L13: 4.7410 L23: -1.7505 REMARK 3 S TENSOR REMARK 3 S11: 0.0424 S12: 0.1569 S13: 0.1037 REMARK 3 S21: 0.2543 S22: -0.0327 S23: -0.4361 REMARK 3 S31: 0.7169 S32: 0.5231 S33: -0.0097 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6TFI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-NOV-19. REMARK 100 THE DEPOSITION ID IS D_1292102164. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-OCT-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS JUNE 17, 2015 REMARK 200 DATA SCALING SOFTWARE : XSCALE JUNE 17, 2015 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 67925 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 44.480 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 5.070 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05300 REMARK 200 FOR THE DATA SET : 17.1500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.96 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.87800 REMARK 200 FOR SHELL : 1.820 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC 5.5.0102 REMARK 200 STARTING MODEL: 3HVL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1 MICROLITER PROTEIN AT 12.1 MG/ML (IN REMARK 280 20 MILLIMOLAR TRIS PH 7.8, 250 MILLIMOLAR NACL, 2.5 MILLIMOLAR REMARK 280 EDTA, 5% (V/V) GLYCEROL, 5 MM DTT), PREINCUBATED WITH 25 REMARK 280 MILLIMOLAR COMPOUND 17 (FROM 500 MILLIMOLAR STOCK IN DMSO) FOR REMARK 280 24 HOURS AT 277 K, MIXED WITH 1 MICROLITER OF RESERVOIR (100 REMARK 280 MILLIMOLAR IMIDAZOLE PH 8.0, 20 % (V/V) MPD). CRYO BUFFER 100 REMARK 280 MILLIMOLAR IMIDAZOLE PH 8.0, 30 % (V/V) MPD, VAPOR DIFFUSION, REMARK 280 HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 42.67800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.82900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.48200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.82900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.67800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.48200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 119 REMARK 465 LYS A 120 REMARK 465 LYS A 121 REMARK 465 GLY A 122 REMARK 465 HIS A 123 REMARK 465 HIS A 124 REMARK 465 HIS A 125 REMARK 465 HIS A 126 REMARK 465 HIS A 127 REMARK 465 HIS A 128 REMARK 465 GLY A 129 REMARK 465 SER A 130 REMARK 465 GLU A 131 REMARK 465 ARG A 132 REMARK 465 THR A 133 REMARK 465 GLY A 134 REMARK 465 THR A 135 REMARK 465 GLN A 136 REMARK 465 PRO A 137 REMARK 465 LEU A 138 REMARK 465 GLY A 139 REMARK 465 VAL A 140 REMARK 465 GLN A 141 REMARK 465 LEU A 178 REMARK 465 SER A 179 REMARK 465 SER A 180 REMARK 465 GLY A 181 REMARK 465 CYS A 182 REMARK 465 GLU A 183 REMARK 465 LEU A 184 REMARK 465 PRO A 185 REMARK 465 GLU A 186 REMARK 465 SER A 187 REMARK 465 LEU A 188 REMARK 465 GLN A 189 REMARK 465 ALA A 190 REMARK 465 GLY A 435 REMARK 465 GLY A 436 REMARK 465 SER A 437 REMARK 465 GLY A 438 REMARK 465 GLY A 439 REMARK 465 SER A 440 REMARK 465 SER A 441 REMARK 465 HIS A 442 REMARK 465 PRO A 461 REMARK 465 SER A 462 REMARK 465 MET B 119 REMARK 465 LYS B 120 REMARK 465 LYS B 121 REMARK 465 GLY B 122 REMARK 465 HIS B 123 REMARK 465 HIS B 124 REMARK 465 HIS B 125 REMARK 465 HIS B 126 REMARK 465 HIS B 127 REMARK 465 HIS B 128 REMARK 465 GLY B 129 REMARK 465 SER B 130 REMARK 465 GLU B 131 REMARK 465 ARG B 132 REMARK 465 THR B 133 REMARK 465 GLY B 134 REMARK 465 THR B 135 REMARK 465 GLN B 136 REMARK 465 PRO B 137 REMARK 465 SER B 179 REMARK 465 SER B 180 REMARK 465 GLY B 181 REMARK 465 CYS B 182 REMARK 465 GLU B 183 REMARK 465 LEU B 184 REMARK 465 PRO B 185 REMARK 465 GLU B 186 REMARK 465 SER B 187 REMARK 465 LEU B 188 REMARK 465 GLN B 189 REMARK 465 ALA B 190 REMARK 465 PRO B 191 REMARK 465 THR B 432 REMARK 465 GLY B 433 REMARK 465 SER B 434 REMARK 465 GLY B 435 REMARK 465 GLY B 436 REMARK 465 SER B 437 REMARK 465 GLY B 438 REMARK 465 GLY B 439 REMARK 465 SER B 440 REMARK 465 SER B 441 REMARK 465 HIS B 442 REMARK 465 SER B 443 REMARK 465 SER B 462 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 301 67.18 -109.17 REMARK 500 PHE A 349 56.59 -92.55 REMARK 500 PHE A 420 -15.59 -146.99 REMARK 500 LEU B 209 79.92 -109.56 REMARK 500 PHE B 349 57.07 -91.86 REMARK 500 PHE B 420 -14.29 -148.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MPD A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MPD B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue N6H B 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS B 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 506 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 507 DBREF 6TFI A 129 434 UNP O75469 NR1I2_HUMAN 129 434 DBREF 6TFI A 443 462 UNP Q15788 NCOA1_HUMAN 681 700 DBREF 6TFI B 129 434 UNP O75469 NR1I2_HUMAN 129 434 DBREF 6TFI B 443 462 UNP Q15788 NCOA1_HUMAN 681 700 SEQADV 6TFI MET A 119 UNP O75469 INITIATING METHIONINE SEQADV 6TFI LYS A 120 UNP O75469 EXPRESSION TAG SEQADV 6TFI LYS A 121 UNP O75469 EXPRESSION TAG SEQADV 6TFI GLY A 122 UNP O75469 EXPRESSION TAG SEQADV 6TFI HIS A 123 UNP O75469 EXPRESSION TAG SEQADV 6TFI HIS A 124 UNP O75469 EXPRESSION TAG SEQADV 6TFI HIS A 125 UNP O75469 EXPRESSION TAG SEQADV 6TFI HIS A 126 UNP O75469 EXPRESSION TAG SEQADV 6TFI HIS A 127 UNP O75469 EXPRESSION TAG SEQADV 6TFI HIS A 128 UNP O75469 EXPRESSION TAG SEQADV 6TFI GLY A 129 UNP O75469 LYS 129 ENGINEERED MUTATION SEQADV 6TFI GLY A 435 UNP O75469 LINKER SEQADV 6TFI GLY A 436 UNP O75469 LINKER SEQADV 6TFI SER A 437 UNP O75469 LINKER SEQADV 6TFI GLY A 438 UNP O75469 LINKER SEQADV 6TFI GLY A 439 UNP O75469 LINKER SEQADV 6TFI SER A 440 UNP O75469 LINKER SEQADV 6TFI SER A 441 UNP O75469 LINKER SEQADV 6TFI HIS A 442 UNP O75469 LINKER SEQADV 6TFI MET B 119 UNP O75469 INITIATING METHIONINE SEQADV 6TFI LYS B 120 UNP O75469 EXPRESSION TAG SEQADV 6TFI LYS B 121 UNP O75469 EXPRESSION TAG SEQADV 6TFI GLY B 122 UNP O75469 EXPRESSION TAG SEQADV 6TFI HIS B 123 UNP O75469 EXPRESSION TAG SEQADV 6TFI HIS B 124 UNP O75469 EXPRESSION TAG SEQADV 6TFI HIS B 125 UNP O75469 EXPRESSION TAG SEQADV 6TFI HIS B 126 UNP O75469 EXPRESSION TAG SEQADV 6TFI HIS B 127 UNP O75469 EXPRESSION TAG SEQADV 6TFI HIS B 128 UNP O75469 EXPRESSION TAG SEQADV 6TFI GLY B 129 UNP O75469 LYS 129 ENGINEERED MUTATION SEQADV 6TFI GLY B 435 UNP O75469 LINKER SEQADV 6TFI GLY B 436 UNP O75469 LINKER SEQADV 6TFI SER B 437 UNP O75469 LINKER SEQADV 6TFI GLY B 438 UNP O75469 LINKER SEQADV 6TFI GLY B 439 UNP O75469 LINKER SEQADV 6TFI SER B 440 UNP O75469 LINKER SEQADV 6TFI SER B 441 UNP O75469 LINKER SEQADV 6TFI HIS B 442 UNP O75469 LINKER SEQRES 1 A 344 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY SER GLU SEQRES 2 A 344 ARG THR GLY THR GLN PRO LEU GLY VAL GLN GLY LEU THR SEQRES 3 A 344 GLU GLU GLN ARG MET MET ILE ARG GLU LEU MET ASP ALA SEQRES 4 A 344 GLN MET LYS THR PHE ASP THR THR PHE SER HIS PHE LYS SEQRES 5 A 344 ASN PHE ARG LEU PRO GLY VAL LEU SER SER GLY CYS GLU SEQRES 6 A 344 LEU PRO GLU SER LEU GLN ALA PRO SER ARG GLU GLU ALA SEQRES 7 A 344 ALA LYS TRP SER GLN VAL ARG LYS ASP LEU CYS SER LEU SEQRES 8 A 344 LYS VAL SER LEU GLN LEU ARG GLY GLU ASP GLY SER VAL SEQRES 9 A 344 TRP ASN TYR LYS PRO PRO ALA ASP SER GLY GLY LYS GLU SEQRES 10 A 344 ILE PHE SER LEU LEU PRO HIS MET ALA ASP MET SER THR SEQRES 11 A 344 TYR MET PHE LYS GLY ILE ILE SER PHE ALA LYS VAL ILE SEQRES 12 A 344 SER TYR PHE ARG ASP LEU PRO ILE GLU ASP GLN ILE SER SEQRES 13 A 344 LEU LEU LYS GLY ALA ALA PHE GLU LEU CYS GLN LEU ARG SEQRES 14 A 344 PHE ASN THR VAL PHE ASN ALA GLU THR GLY THR TRP GLU SEQRES 15 A 344 CYS GLY ARG LEU SER TYR CYS LEU GLU ASP THR ALA GLY SEQRES 16 A 344 GLY PHE GLN GLN LEU LEU LEU GLU PRO MET LEU LYS PHE SEQRES 17 A 344 HIS TYR MET LEU LYS LYS LEU GLN LEU HIS GLU GLU GLU SEQRES 18 A 344 TYR VAL LEU MET GLN ALA ILE SER LEU PHE SER PRO ASP SEQRES 19 A 344 ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL ASP GLN LEU SEQRES 20 A 344 GLN GLU GLN PHE ALA ILE THR LEU LYS SER TYR ILE GLU SEQRES 21 A 344 CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE LEU PHE LEU SEQRES 22 A 344 LYS ILE MET ALA MET LEU THR GLU LEU ARG SER ILE ASN SEQRES 23 A 344 ALA GLN HIS THR GLN ARG LEU LEU ARG ILE GLN ASP ILE SEQRES 24 A 344 HIS PRO PHE ALA THR PRO LEU MET GLN GLU LEU PHE GLY SEQRES 25 A 344 ILE THR GLY SER GLY GLY SER GLY GLY SER SER HIS SER SEQRES 26 A 344 SER LEU THR GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU SEQRES 27 A 344 GLN GLU GLY SER PRO SER SEQRES 1 B 344 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY SER GLU SEQRES 2 B 344 ARG THR GLY THR GLN PRO LEU GLY VAL GLN GLY LEU THR SEQRES 3 B 344 GLU GLU GLN ARG MET MET ILE ARG GLU LEU MET ASP ALA SEQRES 4 B 344 GLN MET LYS THR PHE ASP THR THR PHE SER HIS PHE LYS SEQRES 5 B 344 ASN PHE ARG LEU PRO GLY VAL LEU SER SER GLY CYS GLU SEQRES 6 B 344 LEU PRO GLU SER LEU GLN ALA PRO SER ARG GLU GLU ALA SEQRES 7 B 344 ALA LYS TRP SER GLN VAL ARG LYS ASP LEU CYS SER LEU SEQRES 8 B 344 LYS VAL SER LEU GLN LEU ARG GLY GLU ASP GLY SER VAL SEQRES 9 B 344 TRP ASN TYR LYS PRO PRO ALA ASP SER GLY GLY LYS GLU SEQRES 10 B 344 ILE PHE SER LEU LEU PRO HIS MET ALA ASP MET SER THR SEQRES 11 B 344 TYR MET PHE LYS GLY ILE ILE SER PHE ALA LYS VAL ILE SEQRES 12 B 344 SER TYR PHE ARG ASP LEU PRO ILE GLU ASP GLN ILE SER SEQRES 13 B 344 LEU LEU LYS GLY ALA ALA PHE GLU LEU CYS GLN LEU ARG SEQRES 14 B 344 PHE ASN THR VAL PHE ASN ALA GLU THR GLY THR TRP GLU SEQRES 15 B 344 CYS GLY ARG LEU SER TYR CYS LEU GLU ASP THR ALA GLY SEQRES 16 B 344 GLY PHE GLN GLN LEU LEU LEU GLU PRO MET LEU LYS PHE SEQRES 17 B 344 HIS TYR MET LEU LYS LYS LEU GLN LEU HIS GLU GLU GLU SEQRES 18 B 344 TYR VAL LEU MET GLN ALA ILE SER LEU PHE SER PRO ASP SEQRES 19 B 344 ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL ASP GLN LEU SEQRES 20 B 344 GLN GLU GLN PHE ALA ILE THR LEU LYS SER TYR ILE GLU SEQRES 21 B 344 CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE LEU PHE LEU SEQRES 22 B 344 LYS ILE MET ALA MET LEU THR GLU LEU ARG SER ILE ASN SEQRES 23 B 344 ALA GLN HIS THR GLN ARG LEU LEU ARG ILE GLN ASP ILE SEQRES 24 B 344 HIS PRO PHE ALA THR PRO LEU MET GLN GLU LEU PHE GLY SEQRES 25 B 344 ILE THR GLY SER GLY GLY SER GLY GLY SER SER HIS SER SEQRES 26 B 344 SER LEU THR GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU SEQRES 27 B 344 GLN GLU GLY SER PRO SER HET GOL A 501 6 HET GOL A 502 6 HET MPD A 503 8 HET PO4 A 504 5 HET DMS B 501 4 HET MPD B 502 8 HET N6H B 503 30 HET DMS B 504 4 HET GOL B 505 6 HET GOL B 506 6 HET GOL B 507 6 HETNAM GOL GLYCEROL HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETNAM PO4 PHOSPHATE ION HETNAM DMS DIMETHYL SULFOXIDE HETNAM N6H [2-[(3-CHLOROPHENYL)METHYLAMINO]-7-METHOXY-1,3- HETNAM 2 N6H BENZOXAZOL-5-YL]-(2,2-DIMETHYLMORPHOLIN-4-YL)METHANONE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 GOL 5(C3 H8 O3) FORMUL 5 MPD 2(C6 H14 O2) FORMUL 6 PO4 O4 P 3- FORMUL 7 DMS 2(C2 H6 O S) FORMUL 9 N6H C22 H24 CL N3 O4 FORMUL 14 HOH *360(H2 O) HELIX 1 AA1 THR A 144 PHE A 162 1 19 HELIX 2 AA2 SER A 192 SER A 208 1 17 HELIX 3 AA3 GLY A 233 SER A 238 5 6 HELIX 4 AA4 LEU A 239 ILE A 261 1 23 HELIX 5 AA5 ILE A 261 ASP A 266 1 6 HELIX 6 AA6 PRO A 268 THR A 290 1 23 HELIX 7 AA7 GLY A 314 LEU A 319 1 6 HELIX 8 AA8 GLU A 321 LEU A 333 1 13 HELIX 9 AA9 HIS A 336 PHE A 349 1 14 HELIX 10 AB1 GLN A 358 ARG A 381 1 24 HELIX 11 AB2 PHE A 388 HIS A 418 1 31 HELIX 12 AB3 THR A 422 GLY A 430 1 9 HELIX 13 AB4 HIS A 449 GLU A 458 1 10 HELIX 14 AB5 LEU B 138 LEU B 143 5 6 HELIX 15 AB6 THR B 144 PHE B 162 1 19 HELIX 16 AB7 ARG B 193 SER B 208 1 16 HELIX 17 AB8 GLY B 233 SER B 238 5 6 HELIX 18 AB9 LEU B 239 ILE B 261 1 23 HELIX 19 AC1 ILE B 261 ASP B 266 1 6 HELIX 20 AC2 PRO B 268 THR B 290 1 23 HELIX 21 AC3 GLY B 314 LEU B 319 1 6 HELIX 22 AC4 GLU B 321 LEU B 333 1 13 HELIX 23 AC5 HIS B 336 PHE B 349 1 14 HELIX 24 AC6 GLN B 358 ARG B 381 1 24 HELIX 25 AC7 GLN B 383 ARG B 387 5 5 HELIX 26 AC8 PHE B 388 HIS B 418 1 31 HELIX 27 AC9 THR B 422 GLY B 430 1 9 HELIX 28 AD1 HIS B 449 GLU B 458 1 10 SHEET 1 AA110 PHE A 292 ASN A 293 0 SHEET 2 AA110 THR A 298 CYS A 301 -1 O THR A 298 N ASN A 293 SHEET 3 AA110 LEU A 304 LEU A 308 -1 O LEU A 304 N CYS A 301 SHEET 4 AA110 VAL A 211 ARG A 216 -1 N SER A 212 O CYS A 307 SHEET 5 AA110 VAL A 222 LYS A 226 -1 O TYR A 225 N LEU A 213 SHEET 6 AA110 VAL B 222 LYS B 226 -1 O VAL B 222 N LYS A 226 SHEET 7 AA110 VAL B 211 ARG B 216 -1 N LEU B 213 O TYR B 225 SHEET 8 AA110 LEU B 304 LEU B 308 -1 O SER B 305 N GLN B 214 SHEET 9 AA110 THR B 298 CYS B 301 -1 N TRP B 299 O TYR B 306 SHEET 10 AA110 PHE B 292 ASN B 293 -1 N ASN B 293 O THR B 298 CISPEP 1 GLN A 383 PRO A 384 0 8.24 SITE 1 AC1 5 MET A 329 LEU A 333 LYS A 392 HOH A 655 SITE 2 AC1 5 MET B 159 SITE 1 AC2 5 GLN A 366 MET A 394 THR A 398 HOH A 612 SITE 2 AC2 5 HOH A 661 SITE 1 AC3 2 LEU A 209 GLN A 285 SITE 1 AC4 4 GLU A 337 TYR A 340 HOH A 623 HOH A 683 SITE 1 AC5 2 TRP A 223 VAL B 177 SITE 1 AC6 4 MET B 329 LYS B 392 ALA B 395 HOH B 636 SITE 1 AC7 16 ASP B 205 SER B 208 LEU B 209 VAL B 211 SITE 2 AC7 16 MET B 243 MET B 246 GLN B 285 PHE B 288 SITE 3 AC7 16 TRP B 299 TYR B 306 GLU B 321 MET B 323 SITE 4 AC7 16 LEU B 324 HIS B 407 ARG B 410 ILE B 414 SITE 1 AC8 6 HOH A 777 THR B 290 GLU B 337 TYR B 340 SITE 2 AC8 6 HOH B 605 HOH B 649 SITE 1 AC9 3 GLU B 367 LYS B 374 HOH B 628 SITE 1 AD1 6 ILE B 346 GLN B 366 MET B 394 THR B 398 SITE 2 AD1 6 HOH B 606 HOH B 637 SITE 1 AD2 7 MET B 159 LYS B 160 THR B 161 PHE B 162 SITE 2 AD2 7 ASP B 163 HIS B 168 HOH B 621 CRYST1 85.356 88.964 105.658 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011716 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011241 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009464 0.00000